None listed
Conditions
Interventions
Drug : Patients participating in this clinical study are required to take 2 mg or 5 mg of terrazocin once a day for the next 8 weeks, depending on the significance of the injection.
Sponsors
Hanyang University Guri Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. An adult male over 19 years of age 2. Persons with an IPSS total score of 8 or higher 3. Persons with a maximum urinary speed (Qmax) of less than 15mL/s 4. Persons with a single urinary volume of 150 mL or higher 5. Persons with more than one night urination 6. Those who have agreed to participate in this research under the signature of their own handwriting
Exclusion criteria
Exclusion criteria: 1. Those who are overreacting to Alpha-Blocker drugs 2. Person with bladder neck stenosis and urinary tract stenosis 3. Persons with renal dysfunction (Creatine concentration in the serum >2.0 mg/dL) 4. A person with severe liver failure or with a history of illness. 5. Those with severe cardiovascular disease 6. A person with severe low blood pressure 7. Other persons who are not qualified to participate in this study as the Director of Research judges
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate improvement of IPSS total score | — |
Secondary
| Measure | Time frame |
|---|---|
| change in the number of nocturia;LSEQ scores;Quality of life improvement | — |
Countries
Korea, Republic of
Contacts
Public ContactHyeonkyung Kim
Hanyang University Guri Hospital
Outcome results
None listed